TRADJENTA (linagliptin)
ANTIHYPERGLYCEMIC-DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS · TYPE 2 DIABETES MELLITUS
Boehringer Ingelheim
All drugs.
Search drugs by brand or generic name, or refine the directory by prescription status, class, indication, manufacturer, and specialty.
Enter at least 3 characters to search the full directory.
Results
JANUVIA (sitagliptin phosphate)
ANTIHYPERGLYCEMIC-DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS · TYPE 2 DIABETES MELLITUS
Merck Sharp & Dohme
JANUMET (sitagliptin phosphate/metformin HCl)
BIGUANIDES · TYPE 2 DIABETES MELLITUS
Merck Sharp & Dohme
VICTOZA 2-PAK (liraglutide)
INCRETIN MIMETIC/GLP-1 AND DUAL GIP/GLP-1 RECEPTOR AGONIST · TYPE 2 DIABETES MELLITUS
NOVO NORDISK
JENTADUETO (linagliptin/metformin HCl)
BIGUANIDES · TYPE 2 DIABETES MELLITUS
Boehringer Ingelheim
JANUMET XR (sitagliptin phosphate/metformin HCl)
BIGUANIDES · TYPE 2 DIABETES MELLITUS
Merck Sharp & Dohme
VICTOZA 2-PAK (liraglutide)
INCRETIN MIMETIC/GLP-1 AND DUAL GIP/GLP-1 RECEPTOR AGONIST · TYPE 2 DIABETES MELLITUS
NOVO NORDISK
KAZANO (alogliptin benzoate/metformin HCl)
BIGUANIDES · TYPE 2 DIABETES MELLITUS
Takeda Pharmaceuticals America
NESINA (alogliptin benzoate)
ANTIHYPERGLYCEMIC-DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS · TYPE 2 DIABETES MELLITUS
Takeda Pharmaceuticals America
OSENI (alogliptin benzoate/pioglitazone HCl)
HYPOGLYCEMICS, INSULIN-RESPONSE ENHANCER-THIAZOLIDINEDIONES · TYPE 2 DIABETES MELLITUS
Takeda Pharmaceuticals America
VICTOZA 3-PAK (liraglutide)
INCRETIN MIMETIC/GLP-1 AND DUAL GIP/GLP-1 RECEPTOR AGONIST · TYPE 2 DIABETES MELLITUS
NOVO NORDISK
BYETTA (exenatide)
INCRETIN MIMETIC/GLP-1 AND DUAL GIP/GLP-1 RECEPTOR AGONIST · TYPE 2 DIABETES MELLITUS
AstraZeneca Pharmaceuticals
ONGLYZA (saxagliptin HCl)
ANTIHYPERGLYCEMIC-DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS · TYPE 2 DIABETES MELLITUS
AstraZeneca Pharmaceuticals
TRULICITY (dulaglutide)
INCRETIN MIMETIC/GLP-1 AND DUAL GIP/GLP-1 RECEPTOR AGONIST · TYPE 2 DIABETES MELLITUS ·+1
Eli Lilly and Company
GLYXAMBI (empagliflozin/linagliptin)
ANTIHYPERGLYCEMIC-DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS · TYPE 2 DIABETES MELLITUS
Boehringer Ingelheim
SAXENDA (liraglutide)
DIET AIDS · WEIGHT LOSS MANAGEMENT FOR OBESE PATIENT (BODY MASS INDEX 30 OR GREATER) ·+1
NOVO NORDISK
JENTADUETO XR (linagliptin/metformin HCl)
BIGUANIDES · TYPE 2 DIABETES MELLITUS
Boehringer Ingelheim
XULTOPHY 100-3.6 (insulin degludec/liraglutide)
INTERMEDIATE-, LONG-ACTING, AND COMBINATION INSULINS · TYPE 2 DIABETES MELLITUS
NOVO NORDISK
SOLIQUA 100-33 (insulin glargine,human recombinant analog/lixisenatide)
INTERMEDIATE-, LONG-ACTING, AND COMBINATION INSULINS · TYPE 2 DIABETES MELLITUS
Sanofi-Aventis U.S.
BYDUREON BCISE (exenatide microspheres)
INCRETIN MIMETIC/GLP-1 AND DUAL GIP/GLP-1 RECEPTOR AGONIST · TYPE 2 DIABETES MELLITUS
AstraZeneca Pharmaceuticals
OZEMPIC (semaglutide)
INCRETIN MIMETIC/GLP-1 AND DUAL GIP/GLP-1 RECEPTOR AGONIST · TYPE 2 DIABETES MELLITUS ·+2
NOVO NORDISK
STEGLUJAN (ertugliflozin pidolate/sitagliptin phosphate)
ANTIHYPERGLYCEMIC-DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS · TYPE 2 DIABETES MELLITUS
Merck Sharp & Dohme
RYBELSUS (semaglutide)
INCRETIN MIMETIC/GLP-1 AND DUAL GIP/GLP-1 RECEPTOR AGONIST · TYPE 2 DIABETES MELLITUS ·+1
NOVO NORDISK
TRIJARDY XR (empagliflozin/linagliptin/metformin HCl)
BIGUANIDES · TYPE 2 DIABETES MELLITUS
Boehringer Ingelheim
WEGOVY (semaglutide)
DIET AIDS · WEIGHT LOSS MANAGEMENT FOR OBESE PATIENT (BODY MASS INDEX 30 OR GREATER) ·+3
NOVO NORDISK